8月11日,中国生物制药(01177)盘中下跌4.48%,截至10:10,报7.03元/股,成交3.03亿元。中国生物制药有限公司是一家创新研究和研发驱动型的医药集团,其主要业务包括医药研发、智能化生产以及销售,主要产品包括多种生物药和化学药,特别在肿瘤、肝病、呼吸系统、外科/镇痛四大治疗领域具有优势。公司自从2000年上市以来,在MSCI全球标准指数、恒生指数等多个指数中成为成分股,连续六年入选...
Source Link8月11日,中国生物制药(01177)盘中下跌4.48%,截至10:10,报7.03元/股,成交3.03亿元。中国生物制药有限公司是一家创新研究和研发驱动型的医药集团,其主要业务包括医药研发、智能化生产以及销售,主要产品包括多种生物药和化学药,特别在肿瘤、肝病、呼吸系统、外科/镇痛四大治疗领域具有优势。公司自从2000年上市以来,在MSCI全球标准指数、恒生指数等多个指数中成为成分股,连续六年入选...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.